Dr. Ying Huang
My Social Links

Dr. Ying Huang

Researcher
Western University of Health Sciences, USA

Highest Degree
Ph.D. in Human Cancer Genetics from The Ohio State University, USA

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Pharmacogenomics
62%
Drug Transporter
90%
Chemoprevention
75%
Chemoresistance
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
34
Abstracts
0

Selected Publications

  1. Wang, Z, R. Ravula, M. Cao, M. Chow and Y. Huang, 2010. Transporter-mediated multidrug resistance and its modulation by chinese medicines and other herbal products. Curr. Drug Discov. Technol., 7: 54-66.
    CrossRef  |  PubMed  |  
  2. Wang, S., S. Penchala, S. Prabhu, J. Wang and H.Y. Molecular, 2010. Molecular basis of traditional chinese medicine in cancer chemoprevention. Curr. Drug Discov. Technol., 7: 67-75.
    PubMed  |  Direct Link  |  
  3. Pham, A.N., P.E. Blower, O. Alvarado, R. Ravula, P. Gout and Y. Huang, 2010. Pharmacogenomic approach reveals a role for the xc- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines. J. Pharmacol. Exp. Ther., 332: 949-958.
    CrossRef  |  PubMed  |  Direct Link  |  
  4. Liao, G., C. Wen, K. Irizarry, Y. Huang and K. Mitsouras et al., 2010. Abnormal gene expression in cerebellum of Npc1-/- mice during postnatal development. Brain Res., 1325: 128-140.
    CrossRef  |  PubMed  |  Direct Link  |  
  5. Chow, M.S. and Y. Huang, 2010. Utilizing chinese medicines to improve cancer therapy-fiction or reality?. Curr. Drug Discov. Technol., 7: 1-1.
    CrossRef  |  PubMed  |  
  6. Pham, A.N., J. Wang, J. Fang, Z. Gao and Y. Zhang et al., 2009. Pharmacogenomics approach reveals MRP1 (ABCC1)-mediated resistance to geldanamycins. Pharmaceut. Res., 26: 936-945.
    CrossRef  |  PubMed  |  Direct Link  |  
  7. Harirforoosh, S., L. Fleckenstein, P. Mahajan, O.I. Aruoma, Y. Huang and M. Moridani, 2009. The importance of including topics related to pharmacogenetics, pharmacogenomics and medical genetics in the pharmacy curriculum. Am. J. Pharmac. Educ., 73: 2-3.
    PubMed  |  
  8. Gao, X., L. Lin and Y. Huang, 2009. Application of model selection technique in chemogenomic data analysis. Statist. Anal. Data Mining, 2: 186-191.
    CrossRef  |  Direct Link  |  
  9. Lin, Z., X. Zhang, J. Tuo, Y. Guo and B. Green et al., 2008. A variant of the Cockayne syndrome B gene ERCC6 confers risk of lung cancer. Hum Mutat., 29: 113-122.
    CrossRef  |  PubMed  |  Direct Link  |  
  10. Huang, Y., S. Penchala, A. Pham and J. Wang, 2008. Genetic variations and gene expression of transporters in drug disposition and response. Expert Opin. Drug Metabolism Toxicol., 4: 237-254.
    CrossRef  |  PubMed  |  Direct Link  |  
  11. Wang, J. and Y. Huang, 2007. Pharmacogenomics of sex difference in chemotherapeutic toxicity. Current Drug Discovery Technol., 4: 59-68.
    CrossRef  |  PubMed  |  
  12. Liu, R., P.E. Blower, A. Pham, J. Fang and Z. Dai et al., 2007. Cystine-glutamate transporter SLC7A11 mediates resistance to geldanamycin but not to 17-(allylamino)-17-demethoxygeldanamycin. Mol. Pharmacol., 72: 1637-1646.
    CrossRef  |  PubMed  |  Direct Link  |  
  13. Huang, Y., P.E. Blower, R. Liu, Z. Dai and A. Pham et al., 2007. Chemogenomic analysis identifies geldanamycins as substrates and inhibitors of ABCB1. Pharmaceut. Res., 24: 1702-1712.
    CrossRef  |  PubMed  |  Direct Link  |  
  14. Huang, Y., 2007. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy. Cancer Metastasis Rev., 26: 183-201.
    CrossRef  |  PubMed  |  Direct Link  |  
  15. Dai, Z., Y. Huang, W. Sadee and P.E. Blower, 2007. Chemoinformatics analysis identifies cytotoxic compounds susceptible to chemoresistance mediated by glutathione and cystine/glutamate transport system xc-. J. Med. Chem., 50: 1896-1906.
    CrossRef  |  PubMed  |  Direct Link  |  
  16. Huang, Y. and W. Sadee, 2006. Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells. Cancer Lett., 239: 168-182.
    CrossRef  |  PubMed  |  Direct Link  |  
  17. Dai, Z., C. Barbacioru, Y. Huang and W. Sadee, 2006. Prediction of anticancer drug potency from expression of genes involved in growth factor signaling. Pharmaceut. Res., 23: 336-349.
    CrossRef  |  PubMed  |  Direct Link  |  
  18. Cao, X., L. Fang, S. Gibbs, Y. Huang and Z. Dai et al., 2006. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemother Pharmacol., 59: 495-505.
    CrossRef  |  PubMed  |  Direct Link  |  
  19. Xiao, J.J., Y. Huang, Z. Dai, Z. Liu and J. Chen et al., 2005. Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines. J. Pharmacol. Exper. Therapeutics, 314: 467-475.
    CrossRef  |  PubMed  |  Direct Link  |  
  20. Xiao, J., A.B. Foraker, P.W. Swaan, S. Liu and Y. Huang et al., 2005. Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1. J. Pharmacol. Exp. Therapeutics, 313: 268-276.
    CrossRef  |  PubMed  |  Direct Link  |  
  21. Prasad, M.L., N.S. Pellegata, Y. Huang, H.N. Nagaraja, A. de la Chapelle and R.T. Kloos, 2005. Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod. Pathol., 18: 48-57.
    CrossRef  |  PubMed  |  Direct Link  |  
  22. Huang, Y., Z. Dai, C Barbacioru and W. Sadee, 2005. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res., 65: 7446-7454.
    CrossRef  |  PubMed  |  Direct Link  |  
  23. Huang, Y., P.E. Blower, C. Yang, C. Barbacioru and Z. Dai et al., 2005. Correlating gene expression with chemical scaffolds of cytotoxic agents: Ellipticines as substrates and inhibitors of MDR1. The Pharmacogenomics J., 5: 112-125.
    CrossRef  |  PubMed  |  Direct Link  |  
  24. Frank, N.Y., A. Margaryan, Y. Huang, A.M. Waaga-Gasser and M. Gasser et al., 2005. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res., 65: 4320-4333.
    CrossRef  |  PubMed  |  Direct Link  |  
  25. Prasad, M., Y. Huang, N.S. Pellegata, A. de la Chapelle and RT. Kloos, 2004. Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC. Histopathology, 45: 39-46.
    CrossRef  |  PubMed  |  Direct Link  |  
  26. Prasad, M., N.S. Pellegata, R.T. Kloos, C. Barbacioru, Y. Huang and A. de la Chapelle, 2004. CITED1 protein expression suggests papillary thyroid carcinoma in high-throughput tissue microarray-based study. Thyroid, 14: 169-175.
    CrossRef  |  PubMed  |  Direct Link  |  
  27. Huang, Y., P. Anderle, K.J. Bussey, C. Barbacioru and U. Shankavaram et al., 2004. Membrane transporters and channels: Role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res., 64: 4294-4301.
    CrossRef  |  PubMed  |  Direct Link  |  
  28. Dai, Z., Y. Huang and W. Sadee, 2004. Growth factor signaling and resistance to cancer chemotherapy. Curr. Topics Med. Chem., 4: 1347-1356.
    PubMed  |  Direct Link  |  
  29. Anderle, P., Y. Huang and W. Sadee, 2004. Intestinal membrane transport of drugs and nutrients: genomics of membrane transporters using expression microarrays. Eur. J. Pharmaceut. Sci., 21: 17-24.
    CrossRef  |  PubMed  |  Direct Link  |  
  30. Aldred, M.A., Y. Huang, S. Liyanarachchi, N.S. Pellegata and O. Gimm et al., 2004. Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. J. Clinical Oncol., 22: 3531-3539.
    CrossRef  |  PubMed  |  Direct Link  |  
  31. Huang, Y., A. de la Chapelle and N.S. Pellegata, 2003. Hypermethylation, but not LOH, is associated with the Low Expression of MT1G and CRABP1 in Papillary Thyroid Carcinoma. Intl. J. Cancer, 104: 735-744.
    CrossRef  |  PubMed  |  Direct Link  |  
  32. Huang, Y. and W. Sadee, 2003. Drug sensitivity and resistance genes in cancer chemotherapy: A chemogenomics approach. Drug Discovery Today, 8: 356-363.
    CrossRef  |  PubMed  |  Direct Link  |  
  33. Mailman, M.D., T. Hemingway, R.L. Darsey, C.E. Glasure and Y. Huang et al., 2001. Hybrids monosomal for human chromosome 5 reveal the presence of a Spinal Muscular Atrophy (SMA) carrier with two SMN1 copies on one chromosome. Human Genetics., 108: 109-115.
    CrossRef  |  PubMed  |  Direct Link  |  
  34. Huang, Y., M. Prasad, W.J. Lemon, H. Hampel and F.A. Wright et al., 2001. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc. Natl. Acad. Sci. USA., 98: 15044-15049.
    CrossRef  |  PubMed  |  Direct Link  |